CCDC120 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.045000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.029200E-01
Normal-vs-Stage2
1.831420E-01
Normal-vs-Stage3
8.401800E-01
Normal-vs-Stage4
3.133400E-01
Stage1-vs-Stage2
9.056800E-01
Stage1-vs-Stage3
4.780000E-01
Stage1-vs-Stage4
9.912800E-01
Stage2-vs-Stage3
2.386200E-01
Stage2-vs-Stage4
9.342200E-01
Stage3-vs-Stage4
5.256800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.101800E-01
Normal-vs-AfricanAmerican
3.158600E-01
Normal-vs-Asian
1.231380E-01
Caucasian-vs-AfricanAmerican
6.177400E-01
Caucasian-vs-Asian
1.793000E-01
AfricanAmerican-vs-Asian
7.404800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.252400E-01
Normal-vs-Female
1.973410E-01
Male-vs-Female
8.398000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.235770E-01
Normal-vs-Age(41-60Yrs)
7.357500E-02
Normal-vs-Age(61-80Yrs)
3.124800E-01
Normal-vs-Age(81-100Yrs)
3.218200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.973800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.834600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.337160E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.253820E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.032400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.764200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.356800E-01
Normal-vs-Daily Drinker
1.308230E-01
Normal-vs-Weekly Drinker
2.640600E-01
Normal-vs-Occasional Drinker
1.077450E-01
Normal-vs-Social Drinker
1.429210E-01
Non Drinker-vs-Daily Drinker
2.150800E-01
Non Drinker-vs-Weekly Drinker
8.353800E-01
Non Drinker-vs-Occasional Drinker
2.547000E-01
Non Drinker-vs-Social Drinker
5.955200E-01
Daily Drinker-vs-Weekly Drinker
4.355400E-01
Daily Drinker-vs-Occasional Drinker
9.334200E-01
Daily Drinker-vs-Social Drinker
5.578000E-01
Weekly Drinker-vs-Occasional Drinker
4.711800E-01
Weekly Drinker-vs-Social Drinker
8.046400E-01
Occasional Drinker-vs-Social Drinker
6.007800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.726300E-02
Normal-vs-Grade 2
1.590340E-02
Normal-vs-Grade 3
5.061000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.390500E-02
Grade 1-vs-Grade 3
6.023200E-03
Grade 1-vs-Grade 4
3.726300E-02
Grade 2-vs-Grade 3
3.169600E-01
Grade 2-vs-Grade 4
1.590340E-02
Grade 3-vs-Grade 4
5.061000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.109400E-01
Normal-vs-NonDiabetic
1.205830E-01
Diabetic-vs-NonDiabetic
7.736200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.160290E-02
Normal-vs-NoPancreatitis
2.283400E-01
Pancreatitis-vs-NoPancreatitis
5.863200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.525600E-01
Normal-vs-N1
1.967620E-01
N0-vs-N1
4.305200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.538200E-02
Normal-vs-TP53-NonMutant
4.320400E-01
TP53-Mutant-vs-TP53-NonMutant
1.71198999999733E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
